Page last updated: 2024-11-08

5-methyl-2-hepten-4-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

5-methyl-2-hepten-4-one: shows an intense, hazelnut-like aroma; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5362588
SCHEMBL ID310233
SCHEMBL ID310232
MeSH IDM0368115

Synonyms (32)

Synonym
AKOS015841109
5-methyl-(e)-2-hepten-4-one
(2e)-5-methyl-2-hepten-4-one
5-methyl-2-hepten-4-one, predominantly trans, 98%, fg
5-methylhept-2-en-4-one
(e)-5-methylhept-2-en-4-one
5-methyl-2-hepten-4-one
81925-81-7
fema no. 3761
102322-83-8
5-methyl-2-hepten-4-one, predominantly trans
2-hepten-4-one, 5-methyl-, (e)-
5-methyl-2-hepten-4-one [fhfi]
(e)-5-methyl-2-hepten-4-one
(+/-)-filbertone
8k2s58736f ,
5-methyl-2-hepten-4-one, (+/-)-
unii-8k2s58736f
2-hepten-4-one, 5-methyl-, (2e)-
(+/-)-5-methyl-2-hepten-4-one
SCHEMBL310233
SCHEMBL310232
ARJWAURHQDJJAC-GQCTYLIASA-N
filbertone, (.+/-.)-
AC-33764
mfcd00792509
Q5448299
DTXSID401017670
filbertone,5-methyl-(e)-2-hepten-4-one
AS-76135
CS-W013495
HY-W012779
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's4 (36.36)29.6817
2010's4 (36.36)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]